Evidence map›Paper›PMID 35536231›Full record

Trial reportHealth technology assessment (Winchester, England)2022

An intervention to promote self-management, independence and self-efficacy in people with early-stage dementia: the Journeying through Dementia RCT.

Gail Mountain, Jessica Wright, Cindy L Cooper, Ellen Lee, Kirsty Sprange, Jules Beresford-Dent, Tracey Young, Stephen Walters, Katherine Berry, Tom Dening and 10 more

Open access · diamondAbstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in Health technology assessment (Winchester, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 1 country.

Gail MountainCentre for Applied Dementia Studies, University of Bradford, Bradford, UK.ORCID 0000-0002-5417-7691
Jessica WrightSheffield Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0002-1814-3697
Cindy L CooperSheffield Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0002-2995-5447
Ellen LeeSheffield Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0003-4529-7410
Kirsty SprangeNottingham Clinical Trials Research Unit, University of Nottingham, Nottingham, UK.ORCID 0000-0001-6443-7242
Jules Beresford-DentCentre for Applied Dementia Studies, University of Bradford, Bradford, UK.ORCID 0000-0002-3316-2191
Tracey YoungSchool of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0001-8467-0471
Stephen WaltersSchool of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0001-9000-8126
Katherine BerryManchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.ORCID 0000-0002-7399-5462
Tom DeningDivision of Psychiatry & Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0003-3387-4241
Amanda LobanSheffield Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0001-7089-1580
Emily TurtonSheffield Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0001-5763-9604
Benjamin D ThomasSheffield Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0002-6659-6930
Emma L YoungSheffield Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0001-9797-0123
Benjamin J ThompsonSheffield Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0002-5516-8797
Bethany CrawfordDivision of Psychiatry & Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0003-4549-3948
Claire CraigArt and Design Research Centre, Sheffield Hallam University, Sheffield, UK.ORCID 0000-0002-3475-3292
Peter BowieSheffield Health and Social Care NHS Foundation Trust, Sheffield, UK.ORCID 0000-0002-3022-2275
Esme Moniz-CookFaculty of Health Sciences, University of Hull, Hull, UK.ORCID 0000-0002-7232-4632
Alexis FosterSchool of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0002-7978-2791
University of Sheffield · GBUniversity of Nottingham · GBUniversity of Bradford · GBManchester Academic Health Science Centre · GBSheffield Hallam University · GBSheffield Health and Social Care NHS Foundation Trust · GBUniversity of Hull · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are few effective interventions for dementia.

aimTo determine the clinical effectiveness and cost-effectiveness of an intervention to promote self-management, independence and self-efficacy in people with early-stage dementia.

objectivesTo undertake a randomised controlled trial of the Journeying through Dementia intervention compared with usual care, conduct an internal pilot testing feasibility, assess intervention delivery fidelity and undertake a qualitative exploration of participants' experiences.

designA pragmatic two-arm individually randomised trial analysed by intention to treat.

participantsA total of 480 people diagnosed with mild dementia, with capacity to make informed decisions, living in the community and not participating in other studies, and 350 supporters whom they identified, from 13 locations in England, took part.

interventionThose randomised to the Journeying through Dementia intervention (

main outcome measuresThe primary outcome was Dementia-Related Quality of Life score at 8 months post randomisation, with higher scores representing higher quality of life. Secondary outcomes included resource use, psychological well-being, self-management, instrumental activities of daily living and health-related quality of life. RANDOMISATION AND BLINDING: Participants were randomised in a 1 : 1 ratio. Staff conducting outcome assessments were blinded. DATA SOURCES: Outcome measures were administered in participants' homes at baseline and at 8 and 12 months post randomisation. Interviews were conducted with participants, participating carers and interventionalists.

resultsThe mean Dementia-Related Quality of Life score at 8 months was 93.3 (standard deviation 13.0) in the intervention arm ( LIMITATIONS: Study limitations include recruitment of an active population, delivery challenges and limitations of existing outcome measures.

conclusionsThe Journeying through Dementia programme is not clinically effective, is unlikely to be cost-effective and cannot be recommended in its existing format. FUTURE WORK: Research should focus on the creation of new outcome measures to assess well-being in dementia and on using elements of the intervention, such as enabling enactment in the community.

trial registrationThis trial is registered as ISRCTN17993825.

fundingThis project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full in

Indexed as

DementiaSelf-ManagementActivities of Daily LivingCost-Benefit AnalysisHumansQuality of LifeSelf EfficacyACTIVITIES OF DAILY LIVINGCOST-BENEFIT ANALYSISDEMENTIAEARLY DIAGNOSISGOALSINTENTION TO TREAT ANALYSISOUTCOME ASSESSMENT (HEALTH CARE)QUALITATIVE RESEARCHQUALITY OF LIFERESEARCH DESIGNSELF EFFICACYSELF-MANAGEMENTSURVEYS AND QUESTIONNAIRESWELL-BEING

Identifiers

PMID35536231
PMCPMC9376803
OpenAlexW4280496395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.